Zobrazeno 1 - 10
of 137
pro vyhledávání: '"I. Plasencia"'
Autor:
A Martín López, MÁ Ocaña Gómez, P Joy Carmona, CL Díaz Díaz, J Esquivel Negrín, JA Montero Delgado, A Santos Fagundo, G Avanzini Martínez, FJ Merino Alonso, I Plasencia García, KI Álvarez Tosco
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::223f55a3efde38093e16a2cc1de34ffa
https://doi.org/10.1136/ejhpharm-2023-eahp.385
https://doi.org/10.1136/ejhpharm-2023-eahp.385
Publikováno v:
05.03 - Allergy and immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d04a9ea6e9a74289a5742331cd6d67e
https://doi.org/10.1183/13993003.congress-2022.1361
https://doi.org/10.1183/13993003.congress-2022.1361
Autor:
J Merino Alonso, I Plasencia García, T Betancor García, E Tévar Alfonso, A Ferrer Machín, M Vera Cabrera, CL Diaz Diaz, I González García
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance The acquisition of resistance by bacteria has meant that new antimicrobials appear. Ceftazidime–avibactam is a restricted antibiotic that is used in multiresistant infections that put the patient‘s life at risk. Aim and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c10f89ff5d5b39e3d4b5ac62c1385f17
https://doi.org/10.1136/ejhpharm-2020-eahpconf.340
https://doi.org/10.1136/ejhpharm-2020-eahpconf.340
Autor:
L Díaz Díaz, J Merino Alonso, C Perez Martin, S Hernández Rojas, I González García, M Vera Cabrera, K Álvarez Tosco, T Betancor García, R Mesa Expósito, A Ferrer Machín, I Plasencia García
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Transplanted patients are at risk of developing post-transplant diabetes as a metabolic complication of immunosuppressive therapy, which results in greater therapeutic complexity. Aim and objectives To evaluate the percentag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58243398acc3e0934aff6fe2fe74af86
https://doi.org/10.1136/ejhpharm-2020-eahpconf.229
https://doi.org/10.1136/ejhpharm-2020-eahpconf.229
Autor:
I Plasencia García, L Díaz Díaz, I González García, C. Perez, A Ferrer Machín, J Merino Alonso, E Tévar Alfonso, MA Ocaña Gomez, K Álvarez Tosco, R Mesa Expósito, M Vera Cabrera
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance The consequence of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a hypotonic hyponatraemia. Urea is a well tolerated therapeutic option indicated to correct sodium levels, acting as an osmotic diure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6bd65f858f95e9eca361ec7e4f2efd5
https://doi.org/10.1136/ejhpharm-2020-eahpconf.119
https://doi.org/10.1136/ejhpharm-2020-eahpconf.119
Autor:
M Vera Cabrera, K Álvarez Tosco, MA Ocaña Gomez, JA Martin Conde, A. de León Gil, I Plasencia García, FJ Merino Alonso, C Perez Martin, R Mesa Expósito, E Tevar Alonso, A Ferrer Machín
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance The problem of severe asthma refractory to treatment has been addressed in clinical practice guidelines but there is still a notable percentage of patients poorly controlled, under treated and with inadequate follow-up. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66bcb84821972966e33ef9fac8bbb1c5
https://doi.org/10.1136/ejhpharm-2020-eahpconf.246
https://doi.org/10.1136/ejhpharm-2020-eahpconf.246
Publikováno v:
In Journal of Structural Biology 2007 158(3):386-400
5PSQ-041 Efficacy and safety of cidofovir in the treatment of laryngeal papillomatosis: case reports
Autor:
M Viña, I Plasencia, J Merino, R Mesa, L Diaz, E Tevar, A Ocaña, M Navarro, I Gonzalez, A Puebla
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Laryngeal papillomatosis is a larynx neoplasm due to the human papillomavirus virus (HPV) infection. It can appear during the first year of life, or during adulthood, which increases the probability of becoming malignant. It is characteris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa7cdb4d0fc7b5ed0fd2d49d04e5f5f3
https://doi.org/10.1136/ejhpharm-2019-eahpconf.474
https://doi.org/10.1136/ejhpharm-2019-eahpconf.474
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Vera Cabrera, S Hernández Rojas, JA Morales Barrios, A Ferrer Machín, E Gómez Melini, I Plasencia García, J Merino Alonso
Publikováno v:
Eur J Hosp Pharm
Background Patients undergoing liver transplantation require pharmacological treatment indefinitely and some patients have complications related to this treatment (diabetes, high cholesterol, high blood pressure, impaired renal function, osteoporosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7618903a261ba99c0d80561a691bbbe7
https://europepmc.org/articles/PMC7535708/
https://europepmc.org/articles/PMC7535708/
